Sustainable Environment

Foresee Pharmaceuticals is not classified as a high carbon-intensive industry. Foresee has gradually implemented greenhouse gas inventories, established management strategies and carbon reduction targets, and continuously monitored domestic and international regulatory trends to prepare for potential risks. Foresee's greenhouse gas emissions primarily come from energy use during operations, mainly from electricity and air conditioning-related (fugitive) emissions. In 2023, greenhouse gas emissions rose due to expanding R&D labs and offices. We aim for a 10% reduction in per capita emissions by 2028 compared to 2023. Our strategies include using the SIF platform to reduce patient visits and transportation emissions, along with ongoing process optimization and improved product energy efficiency. In the R&D laboratory established in 2023, over NT$2,132,000 was invested in procurement related to energy-efficient and environmentally friendly green certifications. Specific measures include procuring energy-efficient certified products and equipment with high performance, such as air conditioners, IT devices, LED lighting and green building materials, and regularly maintaining and updating them to sustain energy efficiency.

Foresee Pharmaceuticals’ R&D Site, located in the National Biotechnology Research Park, is primarily responsible for early-stage fundamental research and does not have facilities that discharge large amounts of wastewater, waste, or greenhouse gases. The operation and management of chemical raw materials and toxic substances used in R&D, as well as waste generated from chemical and cell experiments in the laboratory, comply with government environmental regulations. Waste is regularly handled by qualified contractors and reported to the Department of Environmental Protection.